Status:
COMPLETED
The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Prematurity
Eligibility:
All Genders
Up to 8 years
Phase:
PHASE4
Brief Summary
The goal of this research study is to compare the levels of free fatty acids and free bilirubin between two intravenous lipid emulsion products in premature newborns.
Eligibility Criteria
Inclusion
- premature newborns (\<32 weeks gestation, stratified \<28 weeks versus \>28 weeks) \<8 days of age
- receiving lipid infusions \<1 g/kg/day at enrollment
- anticipated to be treated with 3 g/kg/day for a minimum of 48 hours.
Exclusion
- patients with direct hyperbilirubinemia \>1.5 mg/dl
- with suspected sepsis meeting Systemic inflammatory response syndrome (SIRS) criteria
- undergoing treatment with a continuous infusion of morphine
- with a continuous infusion of pressors (dopamine, dobutamine, epinephrine, etc.)
- positive blood cultures
Key Trial Info
Start Date :
March 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 11 2020
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT03857646
Start Date
March 2 2019
End Date
June 11 2020
Last Update
March 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Texas Houston HSC
Houston, Texas, United States, 77030